{"id":"W2565225485","doi":"10.1158/1538-7445.am2015-ct217","title":"Abstract CT217: Phase I/II study of dianhydrogalactitol in patients with recurrent malignant glioblastoma multiforme","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Medicine; Clinical trial; Regimen; Oncology; Cancer; Adverse effect; Internal medicine; Chemotherapy; Dosing; Phases of clinical research; Radiosensitizer; Pharmacology; Radiation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001269126,0.00194654,0.002645276,0.0007120387,0.0004921218,0.001044704,0.001141742,0.00128268,0.00294817],"category_scores_gemma":[0.0005570297,0.0005841383,0.001261574,0.0006947804,0.00094598,0.000705606,0.0004458765,0.002432567,0.00125038],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001174496,"about_ca_system_score_gemma":0.001968336,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002995845,"about_ca_topic_score_gemma":0.00545487,"domain_scores_codex":[0.9996052,0.0001714699,0.00002185241,0.00006224679,0.00004359137,0.00009563108],"domain_scores_gemma":[0.9995865,0.00003029386,0.00005419088,0.00003748578,0.00003977631,0.0002516545],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5044168,0.1245683,0.0131466,0.001672306,0.00294167,0.001046194,0.000685031,0.004879465,0.1520965,0.0006017581,0.01261782,0.1813276],"study_design_scores_gemma":[0.2791687,0.6875426,0.01718232,0.00004612667,0.0006698178,0.0004905293,0.0001048413,0.001663681,0.007750902,0.0001819668,0.005142314,0.00005624974],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906069,0.002975859,0.000441285,0.000517554,0.0001537055,0.002251342,0.001215684,0.0001418942,0.001695782],"genre_scores_gemma":[0.9847075,0.002801731,0.001306141,0.001080568,0.0002008236,0.002420739,0.003909681,0.00004794263,0.003524874],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002995845,"threshold_uncertainty_score":0.009862602,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08462065460431194,"score_gpt":0.4219218915988156,"score_spread":0.3373012369945037,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}